Jul 1, 2022 1:09:17 PM / by Stephanie
Roy S. Herbst, MD, PhD
Yale Cancer Center and Smilow Cancer Hospital
Overall survival from a randomized study for advanced NSCLC previously treated with immunotherapy
Summanta (Monty) Pal, MD
City of Hope
Cabozantinib (C) in combination with atezolizumab (A) in urothelial carcinoma (UC)
Karim Chamie, MDUCLA Health
Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary NMIBC
Interested In Advertising With Us?Click Here To Schedule A MeetingPhone: 949-394-4735Email: advertise@oncologytube.com
Topics: ASCO22
I am the Brand Ambassador and Media Coordinator at OncologyTube.com, and I have interviewed many of you. I look forward to speaking with you about your up-and-coming trials and studies.
